Question from a novice: does the broad protection offered by your vaccine imply that there would be less need for yearly boosters?
replyI have the same question. What do antibody titers look like in early participants?
replyCongratulations and thank you
replyWhat are the best other possible uses for LNP
replyAm I wrong in saying that along with new peptides, mRNA tech has the potential to dramatically upend healthcare as we know it. What else can you do with it or is it just for vaccines you think?
Congratulations to the team! A production ready lipid micelle with reliable human cellular uptake is non trivials. Kudos from the biotech community :)
reply